SpineGuard shares soar after FDA green light - Marketscreener.com
| ALSGD Stock | EUR 0.20 0.01 4.76% |
Slightly above 61% of Spineguard's investor base is looking to short. The analysis of current outlook of investing in Spineguard suggests that many traders are alarmed regarding Spineguard's prospects. Spineguard's investing sentiment overview a quick insight into current market opportunities from investing in Spineguard. Many technical investors use Spineguard stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Spineguard |
SpineGuard shares soar after FDA green light Marketscreener.com
Read at news.google.com
 |
Spineguard Fundamental Analysis
We analyze Spineguard's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spineguard using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spineguard based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Spineguard is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Spineguard Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Spineguard stock to make a market-neutral strategy. Peer analysis of Spineguard could also be used in its relative valuation, which is a method of valuing Spineguard by comparing valuation metrics with similar companies.
Peers
Spineguard Related Equities
| DIM | Sartorius Stedim | 1.94 | ||||
| SK | SEB SA | 1.45 | ||||
| ERF | Eurofins Scientific | 0.96 | ||||
| BIM | Biomerieux | 0.66 |
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.